Dry eye after haematopoietic stem cell transplantation

British Journal of Ophthalmology

Volumn 83, Issue 10, 1999, Pages 1125-1130

  Ogawa, Yoko ^a   Okamoto, Shinichiro ^a   Wakui, Masatoshi ^a   Watanabe, Reiko ^a   Yamada, Masakazu ^a   Yoshino, Mami ^a   Ono, Masafumi ^a   Yang, Hao Yung ^a   Mashima, Yukihiko ^a   Oguchi, Yoshihisa ^a   Ikeda, Yasuo ^a   Tsubota, Kazuo ^b  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; MELPHALAN; METHOTREXATE; PREDNISOLONE; RANIMUSTINE; TACROLIMUS; THIOTEPA;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; AUTOTRANSPLANTATION; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; DRY EYE; EVALUATION; FEMALE; FINGER; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; KERATITIS; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEIBOMIAN GLAND; POSTOPERATIVE COMPLICATION; PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLEX; SCHIRMER TEST; SJOEGREN SYNDROME; SLIT LAMP; STIMULATION; SYMPTOM;

EID: 0032835676     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.10.1125     Document Type: Article

References (34)

1. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991;324:667-74.
2. Thomas ED, Storb R. The development of the scientific foundation of hematopoietic cell transplantation based on animal and human studies. In: Thomas ED, Blume KG, Forman SJ, eds. 2nd ed. Haematopoietic cell transplantation, Oxford: Blackwell, 1998:1-11.
3. Atkinson K. Review: Chronic graft-versus-host disease. Bone Marrow Transplant 1990;5:69-82.
4. Sullivan KM. Graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ, eds. 2nd ed. Haematopoietic cell transplantation, Oxford: Blackwell, 1998:515-36.
5. Hirst LW, Jabs DA, Tutschka PJ, et al. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol 1983;101:580-4.
6. Calissendorff B, Azazi ME, Lönnqvist B. Dry eye syndrome in long-term follow-up of bone marrow transplanted patients. Bone Marrow Transplant 1989;4:675-8.
7. Livesey SJ, Holmes JA,Whirtaker JA. Ocular complications of bone marrow transplantation. Eye 1989;3:271-6.
8. Tanabe S, Hirano J, Murakami M. Manifestations and treatment of ocular graft-versus-host disease in allogeneic bone marrow transplantation, Jpn J Clin Ophthalmol 1992;46:1749-52.
9. Tichelli A, Duell T, Weiss M, et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. Bone Marrow Transplant. 1996;17:1105-11.
10. Mencucci R, Ferrini CR, Bosi A, et al. Ophthalmological aspects in allogeneic bone marrow transplantation: Sjögren-like syndrome in graft-versus-host disease. Eur J Ophthalmol 1997;7:13-8.
11. Yoshino M, Yamada M, Ogawa Y, et al. Dry eye associated with bone marrow transplantation. Folia Ophthalmol Jpn 1997;48:453-5.
12. Toda I, Shinozaki N, Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea 1996;15:120-8.
13. Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea 1993;12:366-8.
14. Tsubota K, Toda I, Yagi Y,et al. Three different types of dry eye syndrome. Cornea 1994;13:202-9.
15. Xu K, Yagi Y, Toda I, et al. Tear function index: a new measure of dry eye. Arch Ophthalmol 1995;113:84-8.
16. Tsubota K. The importance of Schirmer test with nasal stimulation. Am J Ophthalmol 1991;111:106-8.
17. Tsubota K, Xu K, Fujihara T, et al. Decreased reflex tearing is associated with lymphocyte infiltration in lacrimal glands, J Rheumatol 1996;23:313-20.
18. Shimazaki J, Sakata M, Tsubota K, Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 1995;113:1266-70.
19. Shimazaki J. Definition and criteria of dry eye. Ganka (Japan) 1995;37:765-70.
20. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-32.
21. Shimazaki J, Goto E , Ono M, et al. Meibomian gland dysfunction in patients with Sjögren's syndrome. Ophthalmology 1998;105:1485-8.
22. Schulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
23. Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol 1995;233:555-8.
24. Jack MK, Jack GM, Sale GE, et al. Ocular manifestations of graft-v-host disease, Arch Ophthalmol 1983;101:1080-4.
25. Franklin RM, Kenyon KR, Tutschka PJ, et al. Ocular manifestations of graft-vs-host disease. Ophthalmology 1983;90:4-13.
26. Sale GE, Beauchamp MD, Akiyatna M. Parafollicular bulges, but not hair bulb keratinocytes, are attacked in graft-versus-host disease of human skin. Bone Marrow Transplant 1994;14:411-13.
27. Akiyama M, Dale BA, Sun TT, et al. Characterization of hair follicle bulge in human fetal skin:The human fetal bulge is a pool of undifferentiated keratinocytes. J Invest Dermatol 1995;105:844-50.
28. Jester JV, Nicolaides N, Kiss-Palvolgyi I, et al. Meibomian gland dysfunction II. The role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci 1989;30:936-45.
29. Bray LC, Carey PL Proctor SJ, et al. Ocular complications of bone marrow transplantation. Br J Ophthalmol 1991;75:611-14.
30. Parsons JT, Fitzgerald CR, Hood CI, et al. The effects of irradiation on the eye and optic nerve, Int J Radiat Oncol Biol Phys 1983;9:609-22.
31. Fraunfelder FT, Meyer SM. Ocular toxicity of antineoplastic agents. Ophthalmology 1983;90:1-3.
32. Nussenblatt RB, Palenstine AG, Therapeutic review. Cyclosporine: immunology, pharmacology and therapeutic uses, Surv Ophthalmol 1986;31:159-69.
33. Barletta JP, Fanous MM, Margo CE. Corneal and conjunctival toxicity with low-dose cytosine arabinoside. Am J Ophthalmol 1992;113:587-8.
34. Lass JH, Lazarus,HM, Reed MD, et al. Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine. Am J Ophthalmol 1982;94:617-21.